Evidence map›Paper›PMID 22182490›Full record

ArticleBiochimie2012

Nitroxyl (HNO) acutely activates the glucose uptake activity of GLUT1.

Matthew J Salie, Daniel S Oram, David P Kuipers, Jared P Scripture, Jude Chenge, Griffin J MacDonald, Larry L Louters

Open access · greenAbstract read
In one paragraph

Article in Biochimie, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The chemical biology of HNO signaling.Archives of biochemistry and biophysics · 2017
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Matthew J SalieDepartment of Chemistry and Biochemistry, Calvin College, Grand Rapids, MI 49546, USA.
Daniel S Oram
David P Kuipers
Jared P Scripture
Jude Chenge
Griffin J MacDonald
Larry L Louters
Calvin University · US

Funding

The Mechanism for the Acute Activation of GLUT1R15DK081931 · NIDDK · CALVIN UNIVERSITY · PI LOUTERS, LAURENCE LEON · 2009 to 2014
$600k
NIDDK NIH HHS R15 DK081931NIDDK NIH HHS R15 DK08193-1A1
6 · The paper itself

Abstract

Nitroxyl (HNO) is a molecule of significant interest due to its unique pharmacological properties, particularly within the cardiovascular system. A large portion of HNO biological effects can be attributed to its reactivity with protein thiols, where it can generate disulfide bonds. Evidence from studies in erythrocytes suggests that the activity of GLUT1 is enhanced by the formation of an internal disulfide bond. However, there are no reports that document the effects of HNO on glucose uptake. Therefore, we examined the acute effects of Angeli's salt (AS), a HNO donor, on glucose uptake activity of GLUT1 in L929 fibroblast cells. We report that AS stimulates glucose uptake with a maximum effective concentration of 5.0 mM. An initial 7.2-fold increase occurs within 2 min, which decreases and plateaus to a 4.0-fold activation after 10 min. About 60% of the 4.0-fold activation recovers within 10 min, and 40% remains after an hour. The activation is blocked by the pretreatment of cells with thiol-reactive compounds, iodoacetamide (0.75 mM), cinnamaldehyde (2.0 mM), and phenylarsine oxide (10 μM). The effects of AS are not additive to the stimulatory effects of other acute activators of glucose uptake in L929 cells, such as azide (5 mM), berberine (50 μM), or glucose deprivation. These data suggest that GLUT1 is acutely activated in L929 cells by the formation of a disulfide bond, likely within GLUT1 itself.

Indexed as

AnimalsBiological TransportCell LineGlucoseGlucose Transporter Type 1MiceNitritesNitrogen OxidesGlucoseGlucose Transporter Type 1NitritesNitrogen Oxidesnitroxyloxyhyponitrite

Identifiers

PMID22182490
PMCPMC5001157
OpenAlexW2054058038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.